Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (1) Bähring, Sylvia Dr. (1) Bartolomaeus, Theda (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Borodina, Tatiana Dr. (1) Bunse, Mario Dr. (1) Chen, Wei Prof. Dr. (1) Chu, Van Trung Dr. (1) Daniel, Peter Prof. Dr. (2) Daumke, Oliver Prof. Dr. (1) Del Giudice, Simone (1) Diecke, Sebastian Dr. (1) Di Virgilio, Michela Prof. Dr. (2) Forslund, Sofia Dr. (1) Gotthardt, Michael Prof. Dr. (1) Graf, Robin Dr. (1) Henssen, Anton Prof. Dr. med. (1) Heuser, Arnd Dr. (1) Hübner, Norbert Prof. Dr. (2) Izsvak, Zsuzsanna Dr. (1) Janz, Martin Dr. (10) Kammertöns, Thomas Dr. (3) Keller, Ulrich Dr. med. (3) Kempa, Stefan Dr. (2) Kirchner, Marieluise Dr. (2) Klußmann, Enno PD Dr. (1) Kopp, Joachim Dr. (1) Landthaler, Markus Prof. Dr. (4) Langanki, Reika (1) Leisegang, Matthias Prof. Dr. rer. nat. (4) Lewin, Gary Prof. Dr. (1) Liu, Tiannan (1) Marko, Lajos Dr. (1) Mastrobuoni, Guido Dr. (2) Mathas, Stephan Dr. (13) Mertins, Philipp Dr. (3) Minia, Igor Dr. (1) Müller, Dominik Prof. Dr. (1) Na, Il-Kang Dr. (1) Napieczynska, Hanna Dr. (1) Nazare, Marc (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Popova, Elena Dr. (1) Popp, Oliver Dr. (2) Prigione, Alessandro Prof. Dr. (1) Qadri, Fatimunnisa Dr. (1) Rahn, Hans-Peter Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Rhein, Simone Dr. (1) Rosenberger, Leonie Milena (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (22) Sholokh, Anastasiia (1) Siffrin, Volker (1) Simon, Katja Prof. Dr. (1) Sommer, Christian (1) Sporbert, Anje Dr. (1) Spuler, Simone Prof. (1) Sunaga-Franze, Daniele Yumi Dr. (1) Taube, Martin (1) Uckert, Wolfgang Prof. Dr. (3) Villamil, Gabriel (1) Wanker, Erich Prof. Dr. (1) Willimsky, Gerald Dr. (2) Wollert-Wulf, Brigitte (3) Wyler, Emanuel Dr. (2) Zauber, Henrik Dr. (3) Ziehm, Matthias Dr. (1) Zinzen, Robert Patrick Dr. (1) Zühlke, Kerstin Dr. (1) (-) Beule, Dieter Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (10) (-) Lusatis, Simone (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (2) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2014 (4) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (6) (-) 2022 (6) 2023 (6) 2024 (2) AG Müller/Dechend (ECRC) (1) (-) Biology of Malignant Lymphomas (1) Biomedical Image Analysis (1) Flow Cytometry (1) Genetics and Genomics of Cardiovascular Diseases (1) Genetics of Congenital Heart Disease (1) Genomics (2) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Mechanism-based Cancer Therapies (1) Microenvironmental Regulation in Autoimmunity and Cancer (2) Mobile DNA (1) (-) Molecular Immunology and Gene Therapy (10) Proteomics (3) RNA Biology and Posttranscriptional Regulation (3) Systems Biology of Gene Regulatory Elements (1) Translational Bioinformatics (20) Translational Tumorimmunology (1) 11 Results: Active Filter: Beule, Dieter Dr.Blankenstein, Thomas Prof. Dr.Lusatis, SimoneBiology of Malignant LymphomasMolecular Immunology and Gene Therapy200620152022 Sort: Result score Newest to oldest Oldest to newest April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein April 15, 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann August 01, 2022 / Cytotherapy Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy M.F. Lammoglia Cobo C. Welters L. Rosenberger M. Leisegang K. Dietze C. Pircher L. Penter R. Gary L. Bullinger A. Takvorian A. Moosmann K. Dornmair T. Blankenstein T. Kammertöns A. Gerbitz L. Hansmann April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse June 08, 2022 / Sci Adv IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis L. Garnier R. Pick J. Montorfani M. Sun D. Brighouse N. Liaudet T. Kammertoens T. Blankenstein N. Page J. Bernier-Latamani N.L. Tran T.V. Petrova D. Merkler C. Scheiermann S. Hugues February 01, 2022 / Curr Opin Immunol The role of CD4 T cells in rejection of solid tumors L. Poncette J. Bluhm T. Blankenstein October 27, 2022 / J Immunother Cancer H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken Pagination Current page 1 Page 2 Next page Next › Last page Last »
April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
April 15, 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
August 01, 2022 / Cytotherapy Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy M.F. Lammoglia Cobo C. Welters L. Rosenberger M. Leisegang K. Dietze C. Pircher L. Penter R. Gary L. Bullinger A. Takvorian A. Moosmann K. Dornmair T. Blankenstein T. Kammertöns A. Gerbitz L. Hansmann
April 06, 2022 / Cancers Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires C. Grunert G. Willimsky C.A. Peuker S. Rhein L. Hansmann T. Blankenstein E. Blanc D. Beule U. Keller A. Pezzutto A. Busse
June 08, 2022 / Sci Adv IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis L. Garnier R. Pick J. Montorfani M. Sun D. Brighouse N. Liaudet T. Kammertoens T. Blankenstein N. Page J. Bernier-Latamani N.L. Tran T.V. Petrova D. Merkler C. Scheiermann S. Hugues
February 01, 2022 / Curr Opin Immunol The role of CD4 T cells in rejection of solid tumors L. Poncette J. Bluhm T. Blankenstein
October 27, 2022 / J Immunother Cancer H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma L. Immisch G. Papafotiou O. Popp P. Mertins T. Blankenstein G. Willimsky
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken